Australia · Healthcare · AUD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NEXALIS THERAPEUTICS LTD? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | 261.31% | 82.74% | 50.76% | 39.69% | 33.86% | 30.17% |
|---|---|---|---|---|---|---|
| ROA | -168.58% | -163.7% | -235.69% | -288.31% | -354.85% | -435.34% |
| Total Assets | A$1,208.14K | A$817.59K | A$817.59K | A$817.59K | A$817.59K | A$817.59K |
| Net Income | -A$1,618.78K | -A$1,658.10K | -A$1,926.96K | -A$2,357.18K | -A$2,901.25K | -A$3,559.26K |
| Sector average | A$29,738.26K | -A$3,880.45K | -A$2,145.08K |
| -A$11,910.51K |
| -A$30,010.60K |
| -A$55,285.83K |